Global leaders meet to discuss new Ebola diagnostic tools
全球領導人齊聚商討新型伊波拉病毒診斷工具
更新於: 2026年9月22日 上午01:45
In September 2026, global leaders gathered at the 81st United Nations General Assembly in New York to tackle the ongoing Ebola outbreak, specifically caused by the Bundibugyo virus.
2026年9月，全球領導人齊聚紐約參加第81屆聯合國大會，商討如何應對由Bundibugyo病毒引起的伊波拉疫情。
With the WHO declaring the situation a public health emergency, officials from the G20 and health organizations focused on a critical shift: moving diagnostic capabilities from centralized labs to the frontline.
世界衛生組織(WHO)宣布此疫情為國際關注公共衛生緊急事件，G20官員及各衛生組織將重點轉向關鍵的轉變：將診斷能力從中心化實驗室移至前線。
A major highlight was the WHO's July 2026 Emergency Use Listing for the first molecular test for the Bundibugyo virus.
一大亮點是WHO於2026年7月將首款針對Bundibugyo病毒的分子檢測納入緊急使用清單(EUL)。
Innovation is currently focused on portable, point-of-care tools, such as duplex platforms capable of distinguishing between Ebola and Lassa viruses, and integrating sample preparation with PCR technology for faster results in the field.
目前的創新聚焦於便攜式、護理點(point-of-care)檢測工具，例如能區分伊波拉與拉薩病毒的雙重平台(duplex platforms)，以及整合樣本製備與PCR技術，以在實地取得更快速的結果。
Supported by multi-million euro emergency funding, this global initiative aims to move beyond reactive crisis management.
在數百萬歐元緊急資金的支持下，此全球倡議旨在超越被動的危機管理。
